Latest / CareTalk: Healthcare. Unfiltered.
The Business & Science Behind the GLP-1 Boom
Send us Fan Mail
GLP-1 drugs have produced some of the most consistent weight loss results medicine has ever seen. The business of actually getting them to patients is a different story entirely.
David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break down the CVS Caremark formulary reversal on CareTalk, examining what it reveals about the economics of GLP-1 coverage, and why emerging clinical research on cancer, long COVID, and addiction may push these drugs far beyond their original indication.
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.